Symbols / XAIR $0.63 -0.65% Beyond Air, Inc.

Healthcare • Medical Devices • United States • NCM
XAIR Chart
About

Beyond Air, Inc., a commercial-stage medical device and biopharmaceutical company, develops the Lungfit platform, a nitric oxide (NO) generator and delivery system platform. It operates through three segments: Beyond Air, Beyond Cancer, and NeuroNos. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn. It is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired pneumonia, including COVID-19 and bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria (NTM) at home. In addition, the company develops ultra-high concentration (UNO) that is in Phase 1 clinical trial to treat multiple solid and cutaneous tumors; and selective neuronal nitric oxide synthase (nNOS) inhibitor for the treatment of neurological conditions and autism spectrum disorder. It has a collaboration with the Yissum Research Development Company of the Hebrew University of Jerusalem, LTD to acquire the commercial rights for neuronal nitric oxide synthase inhibitors to treat autism spectrum disorder and other neurological conditions. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. was founded in 2011 and is headquartered in Garden City, New York.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Medical Devices Market Cap 6.59M
Enterprise Value 18.74M Income -31.00M Sales 6.92M
Book/sh 0.96 Cash/sh 1.11 Dividend Yield —
Payout 0.00% Employees 61 IPO —
P/E — Forward P/E -0.38 PEG —
P/S 0.95 P/B 0.65 P/C —
EV/EBITDA -0.73 EV/Sales 2.71 Quick Ratio 2.59
Current Ratio 5.12 Debt/Eq 284.71 LT Debt/Eq —
EPS (ttm) -4.47 EPS next Y -1.66 EPS Growth —
Revenue Growth 104.70% Earnings 2026-02-13 ROA -51.20%
ROE -240.21% ROIC — Gross Margin 1.82%
Oper. Margin -3.01% Profit Margin 0.00% Shs Outstand 10.53M
Shs Float 9.41M Short Float 1.13% Short Ratio 0.53
Short Interest — 52W High 5.84 52W Low 0.61
Beta 0.53 Avg Volume 539.56K Volume 142.83K
Target Price $8.67 Recom None Prev Close $0.63
Price $0.63 Change -0.65%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$8.67
Mean price target
2. Current target
$0.63
Latest analyst target
3. DCF / Fair value
$-31.88
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.63
Low
$2.00
High
$14.00
Mean
$8.67

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-27 main D. Boral Capital Buy → Buy $10
2026-03-18 main D. Boral Capital Buy → Buy $10
2026-03-10 main D. Boral Capital Buy → Buy $10
2026-01-21 main D. Boral Capital Buy → Buy $11
2025-11-11 main D. Boral Capital Buy → Buy $11
2025-08-21 main D. Boral Capital Buy → Buy $11
2025-08-13 main D. Boral Capital Buy → Buy $11
2025-07-17 init D. Boral Capital — → Buy $11
2024-08-07 main Piper Sandler Overweight → Overweight $1
2024-06-25 main Piper Sandler Overweight → Overweight $4
2024-06-25 down BTIG Buy → Neutral —
2024-04-30 main Truist Securities Buy → Buy $8
2023-11-14 main Truist Securities Buy → Buy $10
2023-07-28 init Piper Sandler — → Overweight $10
2023-07-21 main Truist Securities Buy → Buy $14
2023-06-23 main Oppenheimer Outperform → Outperform $10
2023-06-15 init BTIG — → Buy $15
2022-06-29 main Truist Securities — → Buy $20
2022-06-29 main Ladenburg Thalmann — → Buy $23
2021-11-12 main Truist Securities — → Buy $16
News
RSS: Latest XAIR news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-07-21 LISI STEVEN A Chief Executive Officer — 6,000 $3.25 $19,491
2025-03-14 CAREY ROBERT F. Director — 1,000,000 $0.25 $250,050
2025-02-19 GAUL MICHAEL A Chief Operating Officer — 6,000 $0.38 $2,294
2024-09-26 CAREY ROBERT F. Director — 1,476,626 $0.50 $744,662
2024-09-26 LISI STEVEN A Chief Executive Officer — 1,476,626 $0.50 $744,662
2024-08-15 LISI STEVEN A Chief Executive Officer — 50,000 $0.37 $18,340
2024-08-14 CAREY ROBERT F. Director — 100,000 $0.40 $39,680
2024-08-14 LUCERA ERICK J. Director — 39,266 $0.40 $15,565
2024-08-14 LISI STEVEN A Chief Executive Officer — 100,000 $0.39 $38,640
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Total Revenue
3.71
+219.67%
1.16
0.00
0.00
Operating Revenue
3.71
+219.67%
1.16
0.00
0.00
Cost Of Revenue
5.37
+117.68%
2.47
+344.32%
0.56
0.00
Reconciled Cost Of Revenue
5.37
+117.68%
2.47
+344.32%
0.56
0.00
Gross Profit
-1.66
-27.24%
-1.31
-135.50%
-0.56
0.00
Operating Expense
42.87
-30.51%
61.70
+19.80%
51.50
+70.49%
30.21
Research And Development
16.86
-30.81%
24.36
+44.93%
16.81
+42.43%
11.80
Selling General And Administration
26.02
-30.32%
37.34
+7.62%
34.69
+88.47%
18.41
General And Administrative Expense
26.02
-30.32%
37.34
+7.62%
34.69
+88.47%
18.41
Other Gand A
26.02
-30.32%
37.34
+7.62%
34.69
+88.47%
18.41
Total Expenses
48.24
-24.82%
64.17
+23.26%
52.06
+72.32%
30.21
Operating Income
-44.54
+29.31%
-63.01
-21.03%
-52.06
-72.32%
-30.21
Total Operating Income As Reported
-44.54
+29.31%
-63.01
-21.03%
-52.06
-27.88%
-40.71
EBITDA
-41.89
+29.04%
-59.03
-1.43%
-58.20
-36.31%
-42.70
Normalized EBITDA
-40.96
+33.32%
-61.42
-4.55%
-58.75
-83.27%
-32.06
Reconciled Depreciation
3.57
+51.83%
2.35
+101.03%
1.17
+98.98%
0.59
EBIT
-45.46
+25.94%
-61.38
-3.39%
-59.37
-37.16%
-43.28
Total Unusual Items
-0.93
-138.96%
2.39
+334.12%
0.55
+105.18%
-10.64
Total Unusual Items Excluding Goodwill
-0.93
-138.96%
2.39
+334.12%
0.55
+105.18%
-10.64
Special Income Charges
-3.19
0.00
0.00
+100.00%
-10.50
Other Special Charges
2.45
+309.20%
0.60
-92.39%
7.86
-25.11%
10.50
Net Income
-46.62
+22.60%
-60.24
-7.93%
-55.82
-29.27%
-43.18
Pretax Income
-48.48
+24.60%
-64.30
-8.24%
-59.40
-34.82%
-44.06
Net Non Operating Interest Income Expense
-3.02
-3.67%
-2.91
-9606.67%
-0.03
+96.13%
-0.78
Interest Expense Non Operating
3.02
+3.67%
2.91
+9606.67%
0.03
-96.13%
0.78
Net Interest Income
-3.02
-3.67%
-2.91
-9606.67%
-0.03
+96.13%
-0.78
Interest Expense
3.02
+3.67%
2.91
+9606.67%
0.03
-96.13%
0.78
Other Income Expense
-0.92
-156.80%
1.62
+122.22%
-7.31
+44.08%
-13.07
Other Non Operating Income Expenses
0.01
+101.17%
-0.77
+90.25%
-7.86
-222.92%
-2.44
Gain On Sale Of Security
2.25
-5.81%
2.39
+334.12%
0.55
+493.57%
-0.14
Tax Provision
0.00
0.00
0.00
0.00
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-48.48
+24.60%
-64.30
-8.24%
-59.40
-34.82%
-44.06
Net Income From Continuing Operation Net Minority Interest
-46.62
+22.60%
-60.24
-7.93%
-55.82
-29.27%
-43.18
Net Income From Continuing And Discontinued Operation
-46.62
+22.60%
-60.24
-7.93%
-55.82
-29.27%
-43.18
Net Income Continuous Operations
-48.48
+24.60%
-64.30
-8.24%
-59.40
-34.82%
-44.06
Minority Interests
1.85
-54.26%
4.05
+13.05%
3.58
+306.46%
0.88
Normalized Income
-45.69
+27.05%
-62.63
-11.12%
-56.37
-73.24%
-32.54
Net Income Common Stockholders
-46.62
+22.60%
-60.24
-7.93%
-55.82
-29.27%
-43.18
Diluted EPS
-13.80
+62.09%
-36.40
+2.15%
-37.20
-10.71%
-33.60
Basic EPS
-13.80
+62.09%
-36.40
+2.15%
-37.20
-10.71%
-33.60
Basic Average Shares
3.39
+104.18%
1.66
+10.63%
1.50
+16.77%
1.28
Diluted Average Shares
3.39
+104.18%
1.66
+10.63%
1.50
+16.77%
1.28
Diluted NI Availto Com Stockholders
-46.62
+22.60%
-60.24
-7.93%
-55.82
-29.27%
-43.18
Gain On Sale Of PPE
-0.74
0.00
—
—
Line Item Trend 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Total Assets
30.06
-47.22%
56.96
-17.15%
68.75
-30.70%
99.20
Current Assets
16.02
-63.54%
43.94
-26.05%
59.41
-36.08%
92.94
Cash Cash Equivalents And Short Term Investments
6.92
-79.93%
34.47
-24.88%
45.88
-42.82%
80.24
Cash And Cash Equivalents
4.67
-59.00%
11.38
-60.98%
29.16
-63.66%
80.24
Other Short Term Investments
2.25
-90.25%
23.09
+38.07%
16.72
0.00
Receivables
0.86
+56.93%
0.55
-15.82%
0.65
+7.78%
0.60
Accounts Receivable
0.71
+122.57%
0.32
0.00
—
Other Receivables
—
—
0.42
+30.43%
0.32
Taxes Receivable
0.15
-34.50%
0.23
-0.87%
0.23
-18.09%
0.28
Inventory
2.42
+13.63%
2.13
+88.40%
1.13
+222.57%
0.35
Prepaid Assets
5.39
-14.25%
6.29
+65.42%
3.80
+203.27%
1.25
Restricted Cash
0.23
+0.43%
0.23
-96.98%
7.61
-23.81%
9.99
Other Current Assets
0.20
-26.71%
0.28
-18.05%
0.34
-33.46%
0.51
Total Non Current Assets
14.04
+7.82%
13.03
+39.45%
9.34
+49.34%
6.25
Net PPE
12.72
+10.74%
11.48
+53.22%
7.50
+78.05%
4.21
Gross PPE
18.22
+25.57%
14.51
+65.82%
8.75
+75.81%
4.98
Accumulated Depreciation
-5.50
-81.88%
-3.02
-141.15%
-1.25
-63.49%
-0.77
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
1.43
+2.80%
1.39
+8.57%
1.28
+90.22%
0.68
Other Properties
16.27
+30.09%
12.50
+81.60%
6.88
+76.63%
3.90
Leases
0.52
-14.87%
0.61
+5.34%
0.58
+43.81%
0.40
Goodwill And Other Intangible Assets
1.22
-14.37%
1.43
-12.56%
1.63
-11.16%
1.84
Other Intangible Assets
1.22
-14.37%
1.43
-12.56%
1.63
-11.16%
1.84
Other Non Current Assets
0.10
-8.85%
0.11
-46.70%
0.21
+2.42%
0.21
Total Liabilities Net Minority Interest
15.72
-47.20%
29.77
+11.43%
26.72
+27.30%
20.99
Current Liabilities
5.00
-56.77%
11.57
-41.52%
19.78
+84.65%
10.71
Payables And Accrued Expenses
3.77
-62.04%
9.94
-46.13%
18.45
+95.80%
9.42
Payables
1.95
+0.10%
1.95
-3.37%
2.02
+78.57%
1.13
Accounts Payable
1.95
+0.10%
1.95
-3.37%
2.02
+78.57%
1.13
Other Payable
—
—
—
4.00
Current Accrued Expenses
1.82
-77.19%
7.99
-51.38%
16.43
+98.14%
8.29
Pensionand Other Post Retirement Benefit Plans Current
—
—
0.98
+140.83%
0.41
Current Debt And Capital Lease Obligation
1.00
-17.49%
1.22
+5.82%
1.15
-4.72%
1.21
Current Debt
0.61
-23.88%
0.80
+3.23%
0.78
-16.40%
0.93
Other Current Borrowings
0.61
-23.88%
0.80
+3.23%
0.78
-16.40%
0.93
Current Capital Lease Obligation
0.40
-5.26%
0.42
+11.17%
0.38
+33.81%
0.28
Current Deferred Liabilities
0.00
-100.00%
0.14
0.00
—
Current Deferred Revenue
0.00
-100.00%
0.14
0.00
—
Other Current Liabilities
0.22
-18.61%
0.27
+49.73%
0.18
+120.48%
0.08
Total Non Current Liabilities Net Minority Interest
10.72
-41.12%
18.21
+162.33%
6.94
-32.47%
10.28
Long Term Debt And Capital Lease Obligation
10.68
-35.72%
16.62
+580.83%
2.44
+7.11%
2.28
Long Term Debt
9.20
-37.52%
14.72
+12167.50%
0.12
-40.00%
0.20
Long Term Capital Lease Obligation
1.49
-21.71%
1.90
-18.22%
2.32
+11.64%
2.08
Tradeand Other Payables Non Current
—
—
—
8.00
Other Non Current Liabilities
—
—
4.50
-43.74%
8.00
Stockholders Equity
13.58
-45.77%
25.05
-33.94%
37.91
-47.85%
72.70
Common Stock Equity
13.58
-45.77%
25.05
-33.94%
37.91
-47.85%
72.70
Capital Stock
0.01
+60.00%
0.01
+66.67%
0.00
+0.00%
0.00
Common Stock
0.01
+60.00%
0.01
+66.67%
0.00
+0.00%
0.00
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
4.13
+79.89%
2.30
+49.33%
1.54
+2.92%
1.49
Ordinary Shares Number
4.13
+79.89%
2.30
+49.33%
1.54
+2.92%
1.49
Additional Paid In Capital
299.98
+13.29%
264.78
+21.83%
217.34
+10.74%
196.27
Retained Earnings
-286.32
-19.45%
-239.70
-33.57%
-179.46
-45.14%
-123.64
Gains Losses Not Affecting Retained Earnings
-0.06
-300.00%
-0.01
-128.30%
0.05
-44.79%
0.10
Treasury Stock
0.03
+0.00%
0.03
+0.00%
0.03
+0.00%
0.03
Minority Interest
0.76
-64.55%
2.14
-48.02%
4.11
-25.29%
5.50
Other Equity Adjustments
-0.06
-300.00%
-0.01
-128.30%
0.05
-44.79%
0.10
Total Equity Gross Minority Interest
14.34
-47.25%
27.19
-35.31%
42.03
-46.26%
78.21
Total Capitalization
22.78
-42.72%
39.77
+4.56%
38.03
-47.83%
72.90
Working Capital
11.02
-65.96%
32.37
-18.32%
39.63
-51.81%
82.23
Invested Capital
23.39
-42.35%
40.57
+4.53%
38.81
-47.43%
73.83
Total Debt
11.69
-34.47%
17.84
+396.58%
3.59
+3.01%
3.49
Net Debt
5.14
+24.09%
4.14
—
—
Capital Lease Obligations
1.88
-18.74%
2.32
-14.13%
2.70
+14.28%
2.36
Net Tangible Assets
12.36
-47.67%
23.62
-34.90%
36.28
-48.80%
70.87
Tangible Book Value
12.36
-47.67%
23.62
-34.90%
36.28
-48.80%
70.87
Derivative Product Liabilities
0.04
-97.61%
1.59
0.00
—
Non Current Accrued Expenses
—
—
4.50
-43.75%
8.00
Other Inventories
—
—
—
0.35
Line Item Trend 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Operating Cash Flow
-38.22
+31.77%
-56.01
-69.69%
-33.01
-42.69%
-23.13
Cash Flow From Continuing Operating Activities
-38.22
+31.77%
-56.02
-69.70%
-33.01
-42.68%
-23.14
Net Income From Continuing Operations
-48.48
+24.60%
-64.30
-8.24%
-59.40
-34.82%
-44.06
Depreciation Amortization Depletion
3.57
+51.83%
2.35
+101.03%
1.17
+98.98%
0.59
Depreciation
3.37
+56.78%
2.15
+122.49%
0.96
+75.45%
0.55
Amortization Cash Flow
0.20
+0.00%
0.20
+0.00%
0.20
+439.47%
0.04
Depreciation And Amortization
3.57
+51.83%
2.35
+101.03%
1.17
+98.98%
0.59
Amortization Of Intangibles
0.20
+0.00%
0.20
+0.00%
0.20
+439.47%
0.04
Other Non Cash Items
1.72
+49.78%
1.15
+115200.00%
-0.00
-100.19%
0.53
Stock Based Compensation
9.15
-57.14%
21.34
+9.10%
19.56
+149.75%
7.83
Provisionand Write Offof Assets
0.18
0.00
-100.00%
0.05
0.00
Asset Impairment Charge
0.51
0.00
—
—
Operating Gains Losses
1.23
+290.99%
-0.64
-374.04%
0.23
+63.19%
0.14
Gain Loss On Investment Securities
-1.55
-135.36%
-0.66
—
—
Unrealized Gain Loss On Investment Securities
0.06
-51.22%
0.12
+1125.00%
-0.01
0.00
Net Foreign Currency Exchange Gain Loss
—
—
0.00
-100.00%
0.14
Gain Loss On Sale Of PPE
0.33
+2126.67%
0.01
-93.62%
0.23
0.00
Change In Working Capital
-6.15
+61.64%
-16.04
-397.39%
5.39
-54.43%
11.83
Change In Receivables
-0.39
-486.14%
0.10
+203.06%
-0.10
-195.15%
0.10
Changes In Account Receivables
-0.39
-22.26%
-0.32
0.00
—
Change In Inventory
-0.47
+53.31%
-1.00
-27.78%
-0.78
0.00
Change In Payables And Accrued Expense
-5.96
+54.78%
-13.18
-334.09%
5.63
-55.14%
12.55
Change In Accrued Expense
-6.36
+49.98%
-12.71
-365.29%
4.79
-62.79%
12.87
Change In Payable
0.40
+185.44%
-0.47
-155.73%
0.84
+356.27%
-0.33
Change In Account Payable
0.40
+185.44%
-0.47
-155.73%
0.84
+356.27%
-0.33
Change In Other Current Assets
1.05
+166.20%
-1.58
-272.44%
0.92
+212.50%
-0.82
Change In Other Current Liabilities
-0.39
-1.05%
-0.38
-38.55%
-0.28
0.00
Investing Cash Flow
14.90
+221.82%
-12.23
+40.57%
-20.59
-1319.79%
-1.45
Cash Flow From Continuing Investing Activities
14.90
+221.82%
-12.23
+40.57%
-20.59
-1320.77%
-1.45
Net PPE Purchase And Sale
-5.88
-2.40%
-5.75
-48.18%
-3.88
-167.56%
-1.45
Purchase Of PPE
-5.88
-2.40%
-5.75
-48.18%
-3.88
-167.56%
-1.45
Sale Of PPE
—
—
0.00
—
Capital Expenditure
-5.88
-2.40%
-5.75
-48.18%
-3.88
-167.56%
-1.45
Net Investment Purchase And Sale
20.78
+420.15%
-6.49
+61.16%
-16.71
0.00
Purchase Of Investment
-30.88
+76.02%
-128.77
-261.15%
-35.66
0.00
Sale Of Investment
51.66
-57.76%
122.28
+545.45%
18.95
0.00
Net Other Investing Changes
0.01
—
0.00
+200.00%
-0.00
Financing Cash Flow
16.65
-61.44%
43.17
+1501.15%
2.70
-96.61%
79.45
Cash Flow From Continuing Financing Activities
16.65
-61.44%
43.17
+1501.15%
2.70
-96.61%
79.45
Net Issuance Payments Of Debt
-6.73
-144.90%
14.98
+1584.94%
-1.01
-371.97%
0.37
Issuance Of Debt
11.32
-28.41%
15.82
0.00
-100.00%
1.03
Repayment Of Debt
-18.05
-2061.92%
-0.83
+17.24%
-1.01
-53.34%
-0.66
Long Term Debt Issuance
11.32
-28.41%
15.82
0.00
-100.00%
1.03
Long Term Debt Payments
-18.05
-2061.92%
-0.83
+17.24%
-1.01
-53.34%
-0.66
Net Long Term Debt Issuance
-6.73
-144.90%
14.98
+1584.94%
-1.01
-371.97%
0.37
Short Term Debt Issuance
—
—
0.00
-100.00%
1.03
Short Term Debt Payments
—
—
-1.01
-53.34%
-0.66
Net Short Term Debt Issuance
—
—
-1.01
-198.06%
1.03
Net Common Stock Issuance
23.01
-17.73%
27.97
+654.84%
3.71
-94.91%
72.83
Proceeds From Stock Option Exercised
0.36
+68.20%
0.22
0.00
-100.00%
6.22
Net Other Financing Charges
—
—
—
0.04
Changes In Cash
-6.67
+73.42%
-25.08
+50.72%
-50.90
-192.77%
54.87
Effect Of Exchange Rate Changes
-0.04
+41.56%
-0.08
-79.07%
-0.04
-144.79%
0.10
Beginning Cash Position
11.61
-68.43%
36.77
-58.08%
87.71
+148.70%
35.27
End Cash Position
4.90
-57.82%
11.61
-68.43%
36.77
-59.25%
90.23
Free Cash Flow
-44.10
+28.59%
-61.76
-67.43%
-36.89
-50.05%
-24.58
Interest Paid Supplemental Data
1.20
-31.95%
1.76
+4786.11%
0.04
-89.41%
0.34
Income Tax Paid Supplemental Data
0.00
0.00
0.00
0.00
Common Stock Issuance
23.01
-17.73%
27.97
+654.84%
3.71
-94.91%
72.83
Issuance Of Capital Stock
23.01
-17.73%
27.97
+654.84%
3.71
-94.91%
72.83
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category